Study of Exparel Versus Epidural for Pain Control After Thoracotomy

NCT02178553 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2020-01-09

Study results available
· View outcomes & findings →

Summary

Unilateral intercostal nerve blocks provide pain control as effectively as a continuous thoracic epidural, and will a lower incidence of side effects.

Conditions

  • Pain Following Thoracotomy Surgery

Interventions

DRUG

Epidural

DRUG

Intercostal Bupivicaine (Exparel)

Sponsors & Collaborators

Principal Investigators

  • James D Hannon, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-15
Primary Completion
2018-10-09
Completion
2019-01-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02178553 on ClinicalTrials.gov